HCM
Highbridge Capital Management’s Biogen BIIB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q4 | – | Sell |
-7,491
| Closed | -$2.65M | – | 294 |
|
2018
Q3 | $2.65M | Buy |
+7,491
| New | +$2.65M | 0.06% | 240 |
|
2018
Q2 | – | Sell |
-54,310
| Closed | -$14.9M | – | 601 |
|
2018
Q1 | $14.9M | Buy |
54,310
+52,710
| +3,294% | +$14.4M | 0.24% | 66 |
|
2017
Q4 | $510K | Buy |
+1,600
| New | +$510K | 0.01% | 508 |
|
2017
Q3 | – | Sell |
-58,007
| Closed | -$15.7M | – | 800 |
|
2017
Q2 | $15.7M | Buy |
58,007
+37,645
| +185% | +$10.2M | 0.23% | 83 |
|
2017
Q1 | $5.57M | Sell |
20,362
-29,405
| -59% | -$8.04M | 0.08% | 237 |
|
2016
Q4 | $14.1M | Buy |
49,767
+44,767
| +895% | +$12.7M | 0.25% | 97 |
|
2016
Q3 | $1.57M | Sell |
5,000
-85,208
| -94% | -$26.7M | 0.02% | 427 |
|
2016
Q2 | $21.8M | Buy |
+90,208
| New | +$21.8M | 0.36% | 65 |
|
2016
Q1 | – | Sell |
-66,479
| Closed | -$20.4M | – | 825 |
|
2015
Q4 | $20.4M | Buy |
66,479
+46,510
| +233% | +$14.2M | 0.31% | 82 |
|
2015
Q3 | $5.83M | Buy |
+19,969
| New | +$5.83M | 0.09% | 232 |
|
2015
Q2 | – | Sell |
-37,340
| Closed | -$15.8M | – | 828 |
|
2015
Q1 | $15.8M | Sell |
37,340
-106,878
| -74% | -$45.1M | 0.22% | 123 |
|
2014
Q4 | $49M | Buy |
144,218
+126,935
| +734% | +$43.1M | 0.63% | 32 |
|
2014
Q3 | $5.72M | Buy |
+17,283
| New | +$5.72M | 0.08% | 260 |
|
2013
Q4 | – | Sell |
-44,441
| Closed | -$10.7M | – | 707 |
|
2013
Q3 | $10.7M | Sell |
44,441
-135,458
| -75% | -$32.6M | 0.11% | 218 |
|
2013
Q2 | $38.7M | Buy |
+179,899
| New | +$38.7M | 0.38% | 46 |
|